InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
首席执行官已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Explore the complete record of transactions filed by McGinnis Christopher A, 管理人员. Insider active across 1 company, notably GoodRx Holdings, Inc.. Cumulatively, 6 disclosures have been recorded. History available since 15 April 2026. The latest transaction was filed on 15 July 2026 (Retenue fiscale). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to McGinnis Christopher A
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报6 总计
36,988 股Class A Common StockSEC:0001809519-26-000138:0
16,294 股@ US$3.010.0048% mcap67.9% 占其流量Class A Common StockSEC:0001809519-26-000138:1
44,779 股Class A Common StockSEC:0001809519-26-000114:0
10,745 股@ US$2.230.0023% mcap100.0% 占其流量Class A Common StockSEC:0001809519-26-000075:1
36,987 股Class A Common StockSEC:0001809519-26-000075:0
179,120 股Class A Common StockSEC:0001809519-26-000014:0
6 条申报中的 6 条
About McGinnis Christopher A
McGinnis Christopher A is Dirigeant at GoodRx Holdings, Inc. The 6 filings in the recent sample cover the period from 2026-02-17 to 2026-07-16, and the most frequent transaction nature is Levée d'options. The amounts shown in the main filings include 42875.08579768929 on 2026-07-16 and 20290.47258484649 on 2026-04-15.
